HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

amsonic acid (DAS)

RN given refers to parent cpd
Also Known As:
DAS; DASSA; DASD; 4,4'-diacetamido-2,2'-stilbene disulfonate; 4,4-diaminostilbene-2,2'-disulfonic acid; DADS; DSD acid; amsonic acid, disodium salt; amsonic acid, sodium salt
Networked: 3611 relevant articles (173 outcomes, 347 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Shukla, Yogeshwer: 12 articles (01/2016 - 01/2002)
2. Allaart, C F: 11 articles (02/2017 - 02/2008)
3. Allaart, Cornelia F: 10 articles (01/2022 - 10/2007)
4. Kerstens, P J S M: 10 articles (02/2017 - 05/2008)
5. Huizinga, T W J: 9 articles (02/2017 - 05/2008)
6. Wu, Zhe Bao: 7 articles (01/2021 - 01/2016)
7. Dijkmans, B A C: 7 articles (05/2013 - 02/2008)
8. Arora, Annu: 7 articles (10/2006 - 01/2002)
9. Montori, Victor M: 6 articles (01/2022 - 05/2007)
10. Wang, Xin: 6 articles (11/2021 - 07/2017)

Related Diseases

1. Rheumatoid Arthritis
03/01/2006 - "To evaluate the Disease Activity Score (DAS) using various aggregated dimensions to quantify treatment outcome in patients with rheumatoid arthritis (RA), in order to determine the best instrument to be used as an endpoint that indicates good response in terms of EULAR response criteria and DAS28 remission criteria, and which satisfies the demands of clinical rheumatology. "
10/01/2023 - "PIV was significantly elevated in the Active RA group (p<0.001) and higher in the Remission group than in the Control group (p=0.001). A PIV value of 353.48 exhibited 71.4% sensitivity, 86.2% specificity, 86.2% PPV, 71.4% NPV, and 78.13% test accuracy for distinguishing active rheumatoid arthritis (p<0.001). A PIV value exceeding 353.48 substantially increased the likelihood of a patient belonging to the active rheumatoid arthritis group, with a 14.62-fold higher probability. Furthermore, the study explored the relationship between clinical and laboratory variables and disease activity in RA patients, finding significant differences in PIV among DAS groups (p=0.025). "
01/01/2018 - "The Aiming for Remission in Rheumatoid Arthritis (ARCTIC) trial found that the addition of PDUS and grey-scale ultrasound (GSUS) to a DAS-based strategy did not produce a significant between-group difference in the primary end point: composite DAS of < 1.6, no swollen joints and no progression in van der Heijde-modified total Sharp score (vdHSS). "
01/01/2023 - "The meta-analysis evidenced a significant effect of yoga and acupuncture interventions in decreasing DAS 28 in patients with rheumatoid arthritis (four RCTs; SMD -2.51 95% CI [-2.89, -2.14], p ≤ 0.001, I2 25.9%); in the yoga subgroup analysis, there was also evidence of improvement in the evaluated outcome (three RCTs; SMD -0.51 95% CI [-0.71, -0.30], p ≤ 0.001, I2 0%). "
11/01/2012 - "The study suggests that the disease activity of rheumatoid arthritis (as assessed by DAS-28 score) has a poor correlation with hand functions (as assessed by M-SACRAH and SF-SACRAH) especially in low disease activity and remission states. "
2. Prolactinoma (Prolactinomas)
3. Neoplasms (Cancer)
4. Rheumatic Diseases (Rheumatism)
5. Pain (Aches)

Related Drugs and Biologics

1. Dopamine Agonists (Dopamine Agonist)
2. allyl sulfide
3. ametantrone (HAQ)
4. Antirheumatic Agents (DMARD)
5. tocilizumab (atlizumab)
6. Dasatinib (BMS 354825)
7. diallyl trisulfide
8. diallyl disulfide (diallyl disulphide)
9. Methotrexate (Mexate)
10. Tyrosine Kinase Inhibitors

Related Therapies and Procedures

1. Therapeutics
2. Aftercare (After-Treatment)
3. Drug Therapy (Chemotherapy)
4. Radiotherapy
5. Biological Therapy